Neil Harris Cohen is Director at Chemomab Therapeutics Ltd. (CMMB). They have made 6 open-market trades across 1 company since 2021, most recently 2026-08-28.
CIK 0001840006
4 open-market purchases totalling $247K since 2021, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CMMB | 33,000 | $42K |
Shares reported on the most recent Form 4, priced at the 2026-09-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMMB | SELL | 2026-08-27 | 2026-09-01 | $2.83 | $7K | -11.4% | -52.5% | — |
| CMMB | SELL | 2022-11-16 | 2022-11-18 | $2.00 | $5K | +2.0% | -1.0% | -3.9% |
| CMMB | BUY | 2022-05-18 | 2022-05-19 | $3.19 | $6K | +2.0% | +14.4% | +6.9% |
| CMMB | BUY | 2022-03-14 | 2022-03-15 | $4.35 | $26K | +20.0% | -8.2% | -19.0% |
| CMMB | BUY | 2021-12-06 | 2021-12-08 | $7.43 | $15K | -18.4% | -14.4% | -53.8% |
| CMMB | BUY | 2021-03-16 | 2021-03-26 | $41.51 | $200K | +74.6% | +12.2% | -31.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.